Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Has Average Target Price of $498.83

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned a consensus rating of “Moderate Buy” from the thirty-one research firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, twenty-two have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $498.83.

Several brokerages have commented on ISRG. Stifel Nicolaus decreased their price target on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. KeyCorp restated an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Wells Fargo & Company reiterated an “overweight” rating and set a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, August 21st. Finally, HSBC lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price for the company. in a report on Thursday, July 30th.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts at Erste Group Bank raised their earnings estimates for ISRG, suggesting improved expectations for the company’s upcoming results and longer-term profitability. Erste Group Bank Analysts Boost Earnings Estimates for ISRG
• Positive Sentiment: Recent results have shown double-digit growth in robotic-surgery procedures, revenue and Intuitive Surgical’s installed base of systems. That underlying operating momentum remains a key support for the investment case despite the stock’s broader underperformance this year. Intuitive Surgical Valuation and Growth
• Positive Sentiment: The shares increased in the prior session and outperformed the broader market that day, reflecting some investor support ahead of the earnings release. ISRG Beats Stock Market Upswing
• Neutral Sentiment: Investors are focused on third-quarter procedure growth, da Vinci system demand, revenue, margins and other operating metrics—not just earnings per share and revenue—to determine whether recent momentum is sustainable. ISRG Ahead of Q3 Earnings
• Negative Sentiment: Expectations are tempered by slowing U.S. procedure growth and headwinds in China. These issues could pressure system placements and margins, increasing the risk of an earnings-related market reaction. ISRG Q3 Earnings Preview
• Negative Sentiment: Despite double-digit growth, shares have declined substantially during 2026 and trade at a premium valuation. Investors are questioning whether a valuation around 33 times expected earnings adequately reflects the company’s growth prospects, particularly if procedure growth slows. ISRG Valuation Analysis

Intuitive Surgical Price Performance

ISRG opened at $426.70 on Wednesday. The firm has a market cap of $150.74 billion, a P/E ratio of 48.88, a PEG ratio of 3.22 and a beta of 1.46. Intuitive Surgical has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a 50 day simple moving average of $391.43 and a two-hundred day simple moving average of $409.44.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The business had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same period last year, the firm earned $1.81 earnings per share. The business’s quarterly revenue was up 18.4% on a year-over-year basis. Equities analysts anticipate that Intuitive Surgical will post 8.87 earnings per share for the current year.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the transaction, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the company’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the transaction, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,370 shares of company stock valued at $4,891,989 in the last quarter. 0.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds have recently made changes to their positions in ISRG. 3Chopt Investment Partners LLC raised its position in Intuitive Surgical by 5.2% during the first quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider’s stock worth $213,000 after acquiring an additional 23 shares during the last quarter. Vermillion Wealth Management Inc. raised its position in shares of Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 25 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co raised its position in shares of Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after purchasing an additional 25 shares during the last quarter. Blue Fin Capital Inc. lifted its position in shares of Intuitive Surgical by 0.5% in the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock valued at $2,210,000 after acquiring an additional 25 shares in the last quarter. Finally, Red Spruce Capital LLC boosted its stake in shares of Intuitive Surgical by 4.1% during the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock valued at $255,000 after acquiring an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.